Skip to main content
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1989 Mar;44(3):378–381.

Branching enzyme activity of cultured amniocytes and chorionic villi: prenatal testing for type IV glycogen storage disease.

B I Brown 1, D H Brown 1
PMCID: PMC1715438  PMID: 2521770

Abstract

Although type IV glycogen storage disease (Andersen disease; McKusick 23250) is considered to be a rare, autosomally recessive disorder, of the more than 600 patients with glycogenosis identified in our laboratory by enzymatic assays, 6% have been shown to be deficient in the glycogen branching enzyme. Most of the 38 patients with type IV glycogen storage disease who are known to us have succumbed at a very early age, with the exception of one male teenager, an apparently healthy 7-year-old male, and several 5-year-old patients. Fourteen pregnancies at risk for branching enzyme deficiency have been monitored using cultured amniotic fluid cells, and four additional pregnancies have been screened using cultured chorionic villi. Essentially no branching enzyme activity was detectable in eight samples (amniocytes); activities within the control range were found in five samples (three amniocyte and two chorionic villi samples); and five samples appeared to have been derived from carriers. In two of the cases lacking branching enzyme activity, in which the pregnancies were terminated and fibroblasts were successfully cultured from the aborted fetuses, no branching enzyme activity was found. Another fetus, which was predicted by antenatal assay to be affected, was carried to term. Skin fibroblasts from this baby were deficient in branching enzyme. Pregnancies at risk for glycogen storage disease due to the deficiency of branching enzyme can be successfully monitored using either cultured chorionic villi or amniocytes.

Full text

PDF
378

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSEN D. H. Familial cirrhosis of the liver with storage of abnormal glycogen. Lab Invest. 1956 Jan-Feb;5(1):11–20. [PubMed] [Google Scholar]
  2. Brown B. I., Brown D. H. Lack of an alpha-1,4-glucan: alpha-1,4-glucan 6-glycosyl transferase in a case of type IV glycogenosis. Proc Natl Acad Sci U S A. 1966 Aug;56(2):725–729. doi: 10.1073/pnas.56.2.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brown D. H., Brown B. I. Studies of the residual glycogen branching enzyme activity present in human skin fibroblasts from patients with type IV glycogen storage disease. Biochem Biophys Res Commun. 1983 Mar 16;111(2):636–643. doi: 10.1016/0006-291x(83)90354-6. [DOI] [PubMed] [Google Scholar]
  4. Howell R. R., Kaback M. M., Brown B. I. Type IV glycogen storage disease: branching enzyme deficiency in skin fibroblasts and possible heterozygote detection. J Pediatr. 1971 Apr;78(4):638–642. doi: 10.1016/s0022-3476(71)80466-3. [DOI] [PubMed] [Google Scholar]
  5. ILLINGWORTH B., CORI G. T. Structure of glycogens and amylopectins. III. Normal and abnormal human glycogen. J Biol Chem. 1952 Dec;199(2):653–660. [PubMed] [Google Scholar]
  6. Legum C. P., Nitowsky H. M. Studies on leukocyte bracher enzyme activity in a family with type IV glycogenosis. J Pediatr. 1969 Jan;74(1):84–89. doi: 10.1016/s0022-3476(69)80011-9. [DOI] [PubMed] [Google Scholar]
  7. Shin Y. S., Steigüber H., Klemm P., Endres W., Schwab O., Wolff G. Branching enzyme in erythrocytes. Detection of type IV glycogenosis homozygotes and heterozygotes. J Inherit Metab Dis. 1988;11 (Suppl 2):252–254. doi: 10.1007/BF01804250. [DOI] [PubMed] [Google Scholar]
  8. Thomas J. A., Schlender K. K., Larner J. A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose. Anal Biochem. 1968 Oct 24;25(1):486–499. doi: 10.1016/0003-2697(68)90127-9. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES